RE:RE:We should be in the money!Here is the most compelling news today that drove a single day MCAP improvement that is 150% the toal of FDA FAST TRACKED TLT ; - )
Hmmmmm ; - ) An independent statistical team reported that the predefined stringent probability threshold for clinical efficacy was met for at least one dose of BLU-5937. The following observations of the interim data were made regarding key aspects of the BLU-5937 product profile:
- At least one dose of BLU-5937 met the stringent predefined probability threshold for a clinically meaningful reduction in placebo-adjusted 24-hour cough frequency;
- Limited taste-related adverse events were observed, consistent with previous BLU-5937 trials;
- No serious adverse events were reported.